Recarbrio 500 mg/500 mg/250 mg powder for solution for infusion
*Company:
MSD Ireland (Human Health) LimitedStatus:
No Recent UpdateLegal Category:
Product subject to medical prescription which may not be renewed (A)Active Ingredient(s):
*Additional information is available within the SPC or upon request to the company
Updated on 10 October 2024
File name
QRD-IE-RECARBRIO-LFT-R029-19092024.pdf
Reasons for updating
- Change to section 6 - date of revision
- Change to MA holder contact details
- Removal of Black Inverted Triangle
Free text change information supplied by the pharmaceutical company
Updates following approval of the Renewal: R/0029 for Recarbrio.
Updated on 04 October 2024
File name
RECARBRIO-H-C-4808-R-029-PI-en-IE-CRT (clean).pdf
Reasons for updating
- Change to section 5.1 - Pharmacodynamic properties
- Change to section 10 - Date of revision of the text
- Removal of Black Inverted Triangle
Legal category:Product subject to medical prescription which may not be renewed (A)
Free text change information supplied by the pharmaceutical company
Updates following approval of the Renewal: R/0029 for Recarbrio.
Updated on 07 February 2023
File name
RECARBRIO-H-C-004808-II-0001-IE-en Nov 2020 (clean).pdf
Reasons for updating
- Document format updated
Legal category:Product subject to medical prescription which may not be renewed (A)
Free text change information supplied by the pharmaceutical company
SPC document format updated to html.
Updated on 25 February 2022
File name
RECARBRIO-H-C-004808-II-0001-IE-en Nov 2020 (clean).pdf
Reasons for updating
- New SPC for new product
Legal category:Product subject to medical prescription which may not be renewed (A)
Free text change information supplied by the pharmaceutical company
New SmPC for new product.
Updated on 25 February 2022
File name
QRD-IE-RECARBRIO-LFT-IAIN006-11022021.pdf
Reasons for updating
- New PIL for new product
Free text change information supplied by the pharmaceutical company
New PIL for new product.